SirT INHIBITORS THAT BIND TO NAD

Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.

Saved in:
Bibliographic Details
Main Authors CURTIS RORY, SOLOMON JONATHAN M, HIXON JEFFREY, MCDONAGH THOMAS E, THOMAS RUSSEL J, PONS JEAN-FRANCOIS, DISTEFANO PETER, NAPPER ANDREW D, HUBER L. JULIE
Format Patent
LanguageEnglish
Published 12.06.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Compound of formula (I) and methods of treating disorders by administering a compound of formula (I) are described herein. Examples of disorders include neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders.
Bibliography:Application Number: US201313902062